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Abstract
We sought to develop a practical model for predicting probability of colorectal cancer (CRC) 
screening completion in a diverse safety-net population and a subsequent framework for targeting 
screening promotion interventions. Data used to construct the models was prospectively collected 
from a CRC screening intervention. Models were cross-validated by randomly splitting the data 
into training and validation samples. The predicted probabilities of screening completion from the 
final model were trichotomized into framework groups and cross-validated by defining cut-points 
in the training sample, applying them to the validation sample, and comparing across samples for 
homogeneity. The final model included demographic and simple psychosocial measures and 
predicted screening behavior adequately (AUROC=0.63). The framework groups (cut-points 0.62 
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(low), 0.74 (medium), and 1.0 (high)) were homogeneous across the two samples. The model and 
framework may be useful for designing and delivering targeted interventions to promote CRC 
screening. Future research should validate the framework groups.
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Colorectal cancer (CRC) is the third leading cause of cancer death in the United States. 
Screening for CRC screening is effective and the United States Preventive Services Task 
Force recommends regular screening for adults ages 50–75.1–5 However, completion of 
recommended screening remains suboptimal; only 65% of all adults are up to date with 
recommended screening practices.6 Among Asian and Hispanic Americans specifically, only 
45% and 47%, respectively, are up to date with CRC screening.7,8
Patient decision support has been shown to increase completion of CRC screening, but 
implementation can be difficult and expensive.9–13 Additionally, without significant follow-
up, uptake of patient decision support materials tends to be low, which can minimize the 
effect on screening rates.11–13 One possible reason for low uptake may be that patient 
decision support materials are not targeted at patients' information needs.14 However, 
identifying the information needs of a patient or a group of patients for targeting may be 
challenging.
One potential approach for identifying information needs is to measure patient 
activation.15,16 Patient activation is defined as a patient's willingness and ability to 
participate in and make health care decisions.17 There is some evidence that patient decision 
support interventions targeted at patient activation level improve participation in preventive 
care more effectively than non-targeted interventions.17,18 Hibbard and colleagues 
developed the Patient Activation Measure (PAM) to formally assess patient activation 
level.16 While the PAM has been validated and shown to be a useful tool for targeting 
interventions, it consists of 13– 22 items, depending on the version, and is therefore time-
intensive to administer and complete. Using a time-intensive instrument such as the PAM to 
identify patients for targeted decision support may not be feasible in a busy clinic setting.19 
It may, alternatively, be possible to identify information needs by identifying how likely a 
patient is to complete CRC screening using existing clinical data and a few simple patient-
reported items.
The goals of this project were twofold: first, to develop a simple, practical model to predict 
the individual probability of completing screening using as few items as possible, while still 
maintaining reasonable predictive accuracy; second, using the results of this model, to 
develop a three-level framework for use in designing and delivering patient decision support 
interventions targeted at the information needs of patients at low, medium, and high 
probability of completing CRC screening in a multi-ethnic, low-income population. 
Presented in this paper is the development of the model and the subsequent intervention 
design framework.
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Methods
Study design
The data used in this analysis come from the CRC Adherence Study, which was a cluster-
randomized trial. Participants were randomized to one of three study arms in which their 
primary care provider offered fecal occult blood test (FOBT) only, colonoscopy only, or a 
choice of either test. The purpose of the study was to estimate the effect of choice on CRC 
screening decision-making and behavior; thus, barriers inherent to the public hospital system 
were reduced or eliminated to the extent possible. A detailed description of the participants' 
recruitment has been reported in the literature.20 Participants were followed-up for CRC 
screening completion for 12 months after study enrollment. This analysis, conducted in 
2013, used data collected at baseline and follow-up. The study was approved by the 
University of Washington Institutional Review Board.
Study participants
Tree clinics in the San Francisco Community Health Network (CHN) participated in the 
study. The CHN is the primary safety net within which the majority of people with low-
income or inadequate or no insurance receive medical care; within the CHN, FOBT and 
colonoscopy are available to all city residents regardless of their insurance status. Eligible 
participants were patients at one of these clinics, aged 50– 79 years, at average risk for CRC, 
and not up-to-date with recommended screening. Participants were enrolled in the study 
between 2007-2008. Eight hundred and six (81%) of 997 study participants had complete 
data and were included in this analysis. Excluded participants were more likely to be male 
(54% vs. 45%) and less likely to be adherent (52% vs. 68%). Among the included 
participants, adherence to any CRC screening test did not differ across the study arms.
Part 1: Developing the model
Dependent variable—The outcome of interest was completion of any CRC screening test 
at 12 months. Fecal occult blood testing was complete when the FOBT kit was returned to 
the study office and, for positive tests, a follow-up colonoscopy was completed. 
Colonoscopy was complete if it was documented as completed in the medical record. 
Research staff called study participants to verify non-completion; self-report of out-of-
system screening was recorded as completion. The dependent variable was modeled using 
logistic regression.
Candidate variables—Prior to beginning construction of the prediction model, a pool of 
candidate variables was selected. These variables were either well represented in the 
literature as being associated with screening behavior or were among psychosocial 
characteristics that measured the Health Belief Model constructs or patient trust in primary 
care provider or trust in the medical profession in general.16,21–23 Prior to constructing the 
prediction models, the candidate variables were characterized according to the difficulty of 
collecting them: 1) Existing data: information likely to be in a patient medical record; 2) 
Simple measures: information not typically in a medical record, but conceptually simple to 
collect (e.g., primary language); or 3) Psychosocial measures: items measuring constructs of 
the Health Belief Model (HBM) and patient trust, which are more difficult to collect. Health 
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Belief Model constructs were measured using items previously developed by Janz and 
colleagues.16,24–26 Patient trust was assessed using two subscales of the Wake Forest Trust 
Scale: trust in primary care provider, which measures the level of trust a patient has for his 
or her personal doctor, and trust in doctors in general, which measures the level of trust a 
patient has in medical care providers as a group.27
Independent variables were all collected using facilitated surveys at baseline with the 
exception of patient trust, which was added to the baseline survey in 2008. Participants who 
enrolled prior to this time completed the trust items at a follow-up visit. A prior analysis 
revealed no meaningful differences in trust based on time of assessment.23 All candidate 
variables are described in detail in the appendix.
Variable selection and model construction—Variable selection was based on our 
previous research, a recent review of the literature, and an existing systematic review.28,29 
Because of the purpose of the framework to result from the model (delivering patient 
education), the risks associated with misclassification (i.e., classifying someone as likely to 
complete screening when they are actually unlikely) are minimal. Therefore, the goal was to 
build a simple and practical model that could be feasibly used in a busy clinic setting to 
inform a targeting framework. Variables were selected iteratively in order to achieve a 
balance between parsimony, in terms of number and complexity of variables, and accuracy, 
in terms of ability to predict CRC screening behavior. Model variables were chosen based 
first on difficulty of collection (existing data, simple measures, psychosocial measures, 
described above) and second on evidence in the literature for association with CRC 
screening behavior. Instead of relying on individual variable significance, which can result in 
over-fitting and poor prognostic performance in new data, whole models were built and 
assessed to find the final model. Ultimately, 15 models were assessed using different 
combinations of the candidate variables.
Model assessment—Cross-validation was used to test the performance of each of the 15 
potential models using randomly subsampled training and validation datasets. Each model 
was built in the “training” sample and assessed in the “validation” sample. The area under 
the receiver operator curve (AUROC), or c-statistic, was calculated to assess predictive 
performance, and the Hosmer-Lemeshow (H-L) statistic for goodness of fit to assess 
calibration.30
In this report, three of the 15 potential models are presented for comparison, from which the 
final model was selected. The three models included in this report were selected to represent 
varying levels of model complexity. To fulfill the goal of a simple and practical model, the 
balance of model performance with number and complexity of the variables necessary to 
power the model was considered. The selected final model was the one that best balanced 
simplicity and practicality with performance.
Part 2: The intervention design framework
Generating the framework groups—Following the selection of the final model, a 
three-level intervention design framework was developed to indicate high, medium, or low 
probability of completing screening based on the individual probabilities of completing 
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screening.9,27,28 First, the individual probabilities of completing CRC screening were 
predicted from the final model in the whole study sample. Next, cut-points were defined in 
the previously defined training dataset by trichotomizing (equally dividing into three groups) 
the predicted probabilities of completing CRC screening, dividing the individuals included 
in the training dataset into three equally sized groups. These groups were the three levels of 
readiness to complete screening (Figure 1).
Evaluating the framework groups—To evaluate the framework, the cut points defined 
in the training dataset were applied to the validation dataset. The distribution of screening 
completion and socio-demographic and psychosocial variables were compared across the 
three groups in the two datasets, and to similar groups described in the literature.9,27 The cut 
points were revised iteratively to increase homogeneity of the comparative groups and 
similarity to the characteristics described in the literature (Figure 1).
Results
Study population
Eight hundred and six participants were included in this analysis. The mean age of 
participants was 58, and most were female (55%), self-reported as either Asian (33%) or 
Hispanic (32%), and spoke English (55%). About 68% completed screening within 12 
months of study enrollment. For this analysis, participants who had no missing data and had 
completed the patient trust survey, added later in the study, were included. The randomly 
selected cross-validation samples were 402 in the training sample and 404 in the validation 
sample (Table 1). There were no differences in demographic characteristics across the 
subsamples. Because of the large number of outcomes, the sample size should be large 
enough to allow for construction of a valid model.29
Part 1: Developing the model
Three different models were constructed and tested using different numbers of covariates. 
All model performance statistics are in Table 2 and model covariates, coefficients, and 
standard errors are in Appendix Table 2.
Model 1: Existing data model—This model used covariates categorized as existing data. 
Included in the model were insurance status, patient gender, age, race/ethnicity, primary care 
provider (PCP) gender, and patient-PCP gender concordance. This model had an AUROC of 
0.59 and was well calibrated (Hosmer-Lemeshow p=0.27). The sensitivity and specificity 
were 94.6% and 10.2%.
Model 2: Existing data and simple measures model—For the next model, several 
variables were added to Model 1. Self-reported health status, family history of CRC, 
language, PCP-patient language concordance, and past PCP recommendation of CRC 
screening were added to those included in Model 1. This model would require that four 
simple measures be collected: health status, family history of CRC, primary language, and 
PCP recommendation of screening. This model had an AUROC of 0.63, and was well 
calibrated (H-L p=0.13). The sensitivity and specificity were 91.0% and 17.3%.
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Model 3: All covariates model—In this model, all candidate variables were included, 
adding to the previous models some additional simple measures, the two patient trust scores, 
and scores for constructs of the Health Belief Model. This model would require the 
collection of the 40 items, including seven items to collect the simple measures, 10 to 
measure trust, and 23 to measure the Health Belief Model constructs. This model had an 
AUROC of 0.61, but was not well calibrated (H-L p<.001). The sensitivity and specificity 
were 88.9% and 21.9%.
Other models—Several other models not reported here were considered. These models 
included variables summarizing the Health Belief Model and patient trust in doctors in 
general. They had either poor performance, poor calibration, or required too many complex 
measures to be useful in a practical scenario.
Model selection: Model 2—The model that best balanced simplicity with accuracy was 
Model 2. While Model 1 does not require any data collection, the predictive ability of the 
model was determined to be too low to be useful. Model 3 did not improve on Model 2's 
predictive ability and required the collection of a larger number of more complex 
psychosocial measures (Table 2).
Part 2: The intervention design framework
The individual predicted probabilities in the training and validation samples had similar 
distributions. The means were similar (0.66 training; 0.68 validation) and both were left-
skewed. Trichotomizing the training sample resulted in three equal groups of 134 individuals 
of low, medium, and high screening probability. Cut points in the predicted probabilities of 
screening completion were 0.62 (low), 0.74 (medium), and 1.0 (high). These cut points were 
then applied to the validation sample. Upon comparison of the distribution of screening 
completion rates and socio-demographic characteristics in the low, medium, and high 
screening probability groups in training and validation samples, few differences were found. 
In the validation sample, the low screening probability group had slightly more males (32% 
vs. 24%, p=.05) (Table 3 , Figure 2, Appendix 3).
Discussion
In this paper, three predictive models were developed and compared, a final model was 
selected, and the results of that final model were used to construct a useful framework for 
designing interventions to promote CRC screening. The three models had different levels of 
complexity, and the goal was to select the model that best balanced simplicity with accuracy. 
The selected final model contained mostly information that is likely to be in a patient 
medical record, supplemented by a few simple measures. The model's AUROC was 0.63, 
and it had adequate ability to discriminate between those who would become screened and 
those who would not.
Our previous research has shown that individuals' psychosocial characteristics, particularly 
trust in primary care provider, are predictive of CRC screening behavior.25 However, in the 
current study, these complex psychosocial characteristics did not improve the predictive 
capability of the model enough to justify the difficulty of the data collection. This result is 
Brenner et al. Page 6
J Health Care Poor Underserved. Author manuscript; available in PMC 2017 July 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
consistent with recent findings reported by Jerant, who found that an intervention targeted at 
psychosocial characteristics was no more effective than a generic intervention at promoting 
CRC screening completion.31 Their targeted intervention did, however, improve knowledge 
and self-efficacy, among other measures, which many argue are important to a high quality 
decision-making process.32,33 The simple psychosocial measures included in the final model 
in this report may be enough to achieve some of the benefit in terms of decision-making 
quality without undo data collection burden. The selected final model requires the collection 
of only four simple measures, fulfilling the goal of simplicity. Additionally, it has an 
adequate predictive ability, fulfilling the goal of reasonable predictive accuracy. We present 
this model as a possible equivalent but simpler alternative measurement of patient activation 
to the PAM, in the context of CRC screening intervention.
The Adherence Study data provides a unique platform to identify individual level 
characteristics that predict CRC screening in the absence of system-level barriers, which 
were largely removed as part of the study.20 Patients who were screened during the study 
period likely represent: 1) patients who would complete CRC screening, regardless of the 
presence or absence of system-level barriers, and 2) patients who want to complete CRC 
screening, but might not in the presence of system-level barriers. Previous research that has 
assessed why some people do not complete CRC screening has found system level barriers 
to be important.34,35 This may suggest that many more patients are interested in completing 
screening than actually do. The framework that was developed can be used to categorize 
individuals into low, medium, and high probability of going on to complete screening in the 
future for the purpose of targeting interventions to the information needs of these groups. 
Because screening behavior was assessed in the near absence of system level barriers likely 
increases the usefulness of the final model and subsequent framework. Notably, however, the 
proposed cut point for the low group was higher than those observed in other studies,9 and 
was numerically close to the cut point for the medium group. Because of the near absence of 
system level barriers, this may be an appropriate representation of patients who would be of 
low and medium likelihood to complete CRC screening in the presence of the existing health 
system.
The framework is designed to be both a model for the design of a targeted intervention and a 
mechanism for the delivery of such interventions. There has been extensive research 
considering effective and efficient methods of CRC screening promotion. Many studies have 
found that highly intensive interventions, usually including counseling of patients, have the 
greatest impact on increasing preventive health behaviors.12,13,36 Other studies, however, 
have shown that, while some populations require intensive interventions, others respond well 
to more modest interventions.10,11 Intensive interventions are often effective, but expensive 
and unsustainable. (Tu, Lewis PIP1) Patients who are unlikely, in their current mindset, to 
complete screening in the near future may not be receptive to intensive interventions. 
Patients who are highly likely to complete screening probably do not need an intensive 
intervention to convince them to complete CRC screening. Patients in the middle, however, 
may benefit the most from an intensive intervention. Interventions designed around the 
framework could combine more and less intensive interventions into one multi-staged 
intervention to provide the appropriate intervention intensity to patients based on how likely 
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it is that they will complete screening. The prediction model could then be used to identify 
which intervention each participant would receive.
This analysis has some limitations. First, this is a secondary analysis of data, and the data 
were not collected for the purpose of building a prediction model. Second, the original study 
had multiple arms and subjects in each of the arms may be different. However, the training 
and validation samples were randomly selected, which should equally distribute any 
differences. Third, the trust measures were not collected from all participants at baseline, 
and some difference could be possible based on time of collection. However, a previous 
analysis did not find differences, and, more importantly, the final model did not use these 
measures. Fourth, the racial/ethnic and socioeconomic composition of the study sample is 
more diverse than the national population, and the model and subsequent framework may 
not be useful in other populations. This is also a major strength of the study, as this 
population has significant CRC screening disparities and remains understudied. Fifth, 
because the methods used for variable selection were data driven, this analysis does not 
answer the question about whether certain demographic groups may be more or less likely to 
complete screening. However, the composition of the framework groups is reflective of 
some of the associative conclusions of the original study.20 Finally, screening behavior in 
this population was in response to an intervention and may differ from screening behavior in 
a usual care setting. However, it is likely a good representation of those who want to 
complete screening and would, subsequently, be responsive to an intervention.
Promoting CRC screening among vulnerable populations is an important public health 
initiative; however, these populations can be difficult to reach. The proposed model and 
subsequent framework described in the paper may be useful for designing and delivering 
targeted interventions to promote CRC screening in similar populations. Future evaluation is 
necessary to validate the framework groups. The use of these groups in a targeted 
intervention should, additionally, be evaluated against the established, but lengthier, PAM 
instrument, and should be tested in different populations.
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Figure 1. 
Model and framework construction.
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Figure 2. 
Intervention Targeting Framework.
Brenner et al. Page 12
J Health Care Poor Underserved. Author manuscript; available in PMC 2017 July 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Brenner et al. Page 13
Table 1
Demographic Characteristics of the Sample
Training Validation Total
n=402 n=404 N=806
Race/Ethnicity
 Asiana 27.4% 33.4% 30.4%
 Latino 36.3% 32.2% 34.2%
 African-American 17.4% 15.6% 16.5%
 Non-Hispanic White or otherb 18.9% 18.8% 18.9%
Language
 English 53.5% 54.7% 54.1%
 Spanish 30.1% 24.0% 27.1%
 Chinese or Other 16.4% 21.3% 18.9%
Screening
 Completed 68.6% 66.6% 67.6%
Gender
 Female 53.7% 56.7% 55.2%
Age
 Mean (sd) 58.5(7.0) 58.0(6.7) 58.2(6.8)
a
Predominantly Chinese
b
Predominantly Caucasian
No significant differences across subsamples
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Table 2
Model Performance Statistics
Model 1 Model 2 Model 3
Hosmer-Lemeshow 9.96 (p=.27) 12.5 (.13) 38.5 (p<0.001)
AUROC 0.59 0.63 0.61
Number of Covariates 6 11 33
Measures to collect 0 4 40
Existing Data Insurance X X X
Gender X X X
Age X X X
Race/Ethnicity X X X
PCP Gender X X X
Gender Concordant X X X
Simple Measures Perceived Health X X
Screening Recommended X X
Screening Discussed X
Language X X
Language Concordant X X
Education X
Income X
Family History CRC X X
Trust PCP Trust Score X
Doctors Trust Score X
HBM Constructs Perceived Susceptibility X
Perceived Severity X
Perceived Benefits X
Perceived Barriers X
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